Search results
Results from the WOW.Com Content Network
Epoetin alfa, sold under the brand name Epogen among others, is a human erythropoietin produced in cell culture using recombinant DNA technology. [ 8 ] [ 9 ] Epoetin alfa is an erythropoiesis-stimulating agent. [ 8 ]
Erythropoiesis-stimulating agents (ESA) are medications which stimulate the bone marrow to make red blood cells. [1] They are used to treat anemia due to end stage kidney disease, chemotherapy, major surgery, or certain treatments in HIV/AIDS. [1] [2] In these situations they decrease the need for blood transfusions. [2]
Preterm infants are often anemic and typically experience heavy blood losses from frequent laboratory testing in the first few weeks of life. [4] Although their anemia is multifactorial, repeated blood sampling and reduced erythropoiesis with extremely low serum levels of erythropoietin (EPO) are major causative factors.
n/a n/a Ensembl n/a n/a UniProt n a n/a RefSeq (mRNA) n/a n/a RefSeq (protein) n/a n/a Location (UCSC) n/a n/a PubMed search n/a n/a Wikidata View/Edit Human Erythropoietin (/ ɪ ˌ r ɪ θ r oʊ ˈ p ɔɪ. ɪ t ɪ n, - r ə -, - p ɔɪ ˈ ɛ t ɪ n, - ˈ iː t ɪ n / ; EPO), also known as erythropoetin, haematopoietin, or haemopoietin, is a glycoprotein cytokine secreted mainly by the kidneys ...
Epoetin beta (), sold under the brand name Neorecormon among others, is a synthetic, recombinant [4] form of erythropoietin, a protein that promotes the production of red blood cells.
English: Radiation Dose Chart by Randall Munroe as part of the webcomic xkcd (SVG version of ). In response to concerns about the radioactivity released by the Fukushima Daiichi nuclear disaster:Fukushima Daiichi nuclear disaster in 2011, and to remedy what he described as "confusing" reporting on radiation levels in the media, Munroe created a chart of comparative radiation exposure levels.
Upload file; Special pages; Permanent link; Page information; Cite this page; Get shortened URL; Download QR code; Print/export Download as PDF;
In 1983 his team successfully established the gene coding for it [2] and recombinant human erythropoietin was approved by the US FDA in June 1989 [3] with the generic name epoetin alpha, tradename Epogen. [4] [5] Lin was also engaged in developing novel pharmaceutics and studying their molecular mechanisms.